Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Takeo Maekawa"'
Autor:
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito, Takeo Maekawa, Shoichiro Ishizuki, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Koji Yoshino, Yasuhiro Fujisawa, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Satoshi Fukushima, Yoshihide Asano, Taku Fujimura
Publikováno v:
Cancers, Vol 16, Iss 15, p 2755 (2024)
Background: Adjuvant therapy has improved the clinical prognosis for postoperative melanoma patients. However, the long-term efficacy of this therapy on the melanoma acral and mucosal subtypes has not been fully evaluated in previous trials. This stu
Externí odkaz:
https://doaj.org/article/1263fcf599ec44d1a321e84f93e22d4a
Autor:
Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, Koji Yoshino, Yukiko Kiniwa, Shuichi Ohe, Taiki Isei, Tatsuya Takenouchi, Hiroshi Kato, Satoru Mizuhashi, Satoshi Fukushima, Yosuke Yamamoto, Takashi Inozume, Yasuhiro Fujisawa, Osamu Yamasaki, Yasuhiro Nakamura, Jun Asai, Takeo Maekawa, Takeru Funakoshi, Shigeto Matsushita, Eiji Nakano, Kohei Oashi, Junji Kato, Hisashi Uhara, Takuya Miyagawa, Hiroshi Uchi, Naohito Hatta, Keita Tsutsui, Taku Maeda, Taisuke Matsuya, Hiroto Yanagisawa, Ikko Muto, Mao Okumura, Dai Ogata, Naoya Yamazaki
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17967-17980 (2023)
Abstract Background Anti‐PD‐1‐based immunotherapy is considered a preferred first‐line treatment for advanced BRAF V600‐mutant melanoma. However, a recent international multi‐center study suggested that the efficacy of immunotherapy is po
Externí odkaz:
https://doaj.org/article/7bd38e76e920444a8356acd6025d9a4c
Autor:
Fuminori Katsumata, Koji Kamiya, Hitomi Miyauchi, Hirofumi Okada, Atsuko Sato, Takeo Maekawa, Mayumi Komine, Mamitaro Ohtsuki
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 4, Pp 129-131 (2023)
Abstract Dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP‐FS) is a rare variant, with higher rates of recurrence and metastasis than DFSP. Detection of the collagen type I alpha 1 (COL1A1)–platelet‐derived growth facto
Externí odkaz:
https://doaj.org/article/771743d9e5d6465eb3a155cb25132cfb
Autor:
Tatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, Yukiko Kiniwa, Osamu Yamasaki, Shusuke Yoshikawa, Takashi Inozume, Hiroshi Kato, Yasuo Nakai, Satoshi Fukushima, Tatsuya Takenouchi, Takeo Maekawa, Shigeto Matsushita, Atsushi Otsuka, Motoo Nomura, Natsuki Baba, Taiki Isei, Shintaro Saito, Noriki Fujimoto, Ryo Tanaka, Takahide Kaneko, Yutaka Kuwatsuka, Taisuke Matsuya, Kotaro Nagase, Masazumi Onishi, Takehiro Onuma, Yasuhiro Nakamura
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundAnti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1 MF), particularly in acral mel
Externí odkaz:
https://doaj.org/article/d92b81c82c6941559fafef15d965897b
Autor:
Daiki Karube, Koji Kamiya, Atsuko Sato, Takeo Maekawa, Shin Kabasawa, Mayumi Komine, Mamitaro Ohtsuki
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 5, Pp 192-193 (2023)
Externí odkaz:
https://doaj.org/article/645566fd313e40e7b629e46cbf4670f3
Autor:
Taku Fujimura, Sadanori Furudate, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Akira Hashimoto, Yusuke Muto, Kentaro Ohuchi, Ryo Amagai, Yumi Kambayashi, Yasuhiro Fujisawa
Publikováno v:
Skin Health and Disease, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract Cutaneous angiosarcoma (CAS) is rare and most previous studies of CAS have been small case series, and randomized, phase II studies of CAS are limited. Since treatment options for CAS are controversial, and because only paclitaxel should be
Externí odkaz:
https://doaj.org/article/62140aaaf0b9479cab088d4c86f3c9fd
Autor:
Soichiro Kado, Koji Kamiya, Meijuan Jin, Miho Kimura, Md Razib Hossain, Takeo Maekawa, Mayumi Komine, Mamitaro Ohtsuki
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 4, Iss 6, Pp 154-158 (2021)
Abstract Objectives The aim of this study was to evaluate the expression of GCDFP15 and GATA‐binding protein 3 (GATA‐3) in extramammary Paget's disease (EMPD) skin and serum samples and to assess their availability as tumor markers for the diagno
Externí odkaz:
https://doaj.org/article/52d6ac78eedc41268d961a26aacb651c
Autor:
Okuto Iwasawa, Koji Kamiya, Takayuki Suzuki, Shinya Watanabe, Longzhu Cui, Daiki Karube, Soichiro Kado, Takeo Maekawa, Mayumi Komine, Mamitaro Ohtsuki
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 6, Iss 2, Pp 61-62 (2023)
Externí odkaz:
https://doaj.org/article/2cd68d960d874bdab6b2227a0b6c110e
Autor:
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Taku Fujimura
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Anti-PD-1 antibodies (Abs) are among the optimal adjuvant therapies for melanoma at high risk of recurrence, especially BRAF wild-type melanoma, but the anti-tumour effects of anti-PD-1 Abs in the adjuvant setting for acral melanoma have not been eva
Externí odkaz:
https://doaj.org/article/fa5b1bbbd6dc44ed9313f06675f9d562
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 5, Iss 3, Pp 114-115 (2022)
Externí odkaz:
https://doaj.org/article/34eec08eb4d240e6beaaf0e20f67254d